Full-Time

Applied AI Engineer

Tandem

Tandem

201-500 employees

Language exchange app connecting native speakers

Compensation Overview

$170k - $300k/yr

Company Does Not Provide H1B Sponsorship

New York, NY, USA

In Person

Category
AI & Machine Learning (2)
,
Required Skills
LLM
Kubernetes
Python
React.js
Tensorflow
Pytorch
Postgres
TypeScript
Requirements
  • Strong programming skills and general Computer Science knowledge
  • Experience driving AI projects end-to-end — from model development and data infrastructure to production deployment and real-world iteration
  • Proficiency with modern AI/ML technologies (e.g., LLM APIs, PyTorch, TensorFlow) and a strong foundation in full-stack web development (Python, React, TypeScript, PostgreSQL, Kubernetes)
  • Strong written and verbal communication that allows you to be an effective participant in both internal debates and external relationships
  • Track record of moving quickly, finding shortcuts, and going to unreasonable lengths to deliver on goals
  • High NPS with your former teammates
Responsibilities
  • Scope and spearhead AI augmentation and automation projects across our product surface area, including: Unintuitive classifications, Data extraction and summarization, Precise content generation, Reference-based search and question answering, Process outcome prediction, Probabilistic triggering of workflows, and Multimodal model-powered bots
  • Drive zero-to-one product development from conceptualization through production, collaborating with our go-to-market and operations teams
  • Stay on top of emerging AI methods and drive decisions around which models and techniques we use, including where we fine-tune and train models
  • Establish research strategies for various AI methods, including experimentation and evaluation protocols that control for both accuracy and consistency
  • Prototype and productionize AI functionality and agents, incorporating real-world feedback to refine them
  • Participate actively in client engagements, working directly with customers to understand requirements and deliver innovative solutions
  • Develop engineering process, tools, and systems to support faster AI product development (e.g., build a one-click eval system) and scaling (e.g., model invocation efficiency)
  • Work closely with the rest of our team and CEO to make business decisions as we balance speed of growth and long-term profitability
  • Decipher and automate complex, branching workflows for insurance coverage, affordability programs, and fulfillment + Combining AI/ML approaches to achieve high precision document classification, unstructured data extraction, and reference-based question answering + Automating multi-step, path-dependent processes, using a combination of RPA/scraping approaches to navigate and operate third-party platforms + Building a state machine that drives system decisions and handles failure modes across a set of processes that are technically independent but practically intertwined
  • Scale across a growing range of drug classes, patient populations, and provider markets + Making our data and ML pipelines robust to variation and inconsistency in input data formats (e.g., clinical documentation structure and style) + Leveraging empirical data to build and continuously update our understanding of opaque external systems (e.g., insurance company policies) + Creating consumer-grade experiences for patients, physicians, and other users that incorporate intuitive AI-powered workflows
  • Use our network to help biopharma partners accelerate drug development, launch, and access + Translating large volumes of heterogeneous data into reliable insights, informing decisions like clinical indication selection, launch markets, and insurer negotiations + Developing predictive and simulation models to forecast outcomes such as clinical trial site performance, drug adoption rates, and the impact of rebates/subsidies + Using real-time data and direct engagement channels to enroll criteria-matching patients and physicians in clinical studies and access programs
Desired Qualifications
  • If you don’t meet every single one, you should still consider applying!
  • We’re excited to work with people from underrepresented backgrounds, and we encourage people from all backgrounds to apply.

Tandem is a mobile language learning app that connects users with native speakers worldwide for peer-to-peer language practice. Users define their language goals, interests, and location to find partners and chat with them to practice speaking. The app uses a freemium model: free basic features include finding and messaging language partners, while Tandem Pro, the paid tier, adds features such as unlimited translations, profile visitor insights, and location-based partner matching. This setup distinguishes Tandem by emphasizing direct practice with native speakers and social learning within a global community, rather than traditional classroom-style lessons. Its goal is to make language learning more interactive and social by enabling real conversations across borders.

Company Size

201-500

Company Stage

Late Stage VC

Total Funding

$100M

Headquarters

New York City, New York

Founded

2023

Simplify Jobs

Simplify's Take

What believers are saying

  • Founded 2014 in Hannover with millions of global users.
  • Freemium model allows five free conversations boosting adoption.
  • Pro subscription unlocks unlimited translations driving revenue.

What critics are saying

  • BoldVoice diverts English learners to AI feedback in 6 months.
  • Duolingo captures freemium users via gamification in 3 months.
  • GPT-4o eliminates peer matching need within 12 months.

What makes Tandem unique

  • Tandem supports over 300 languages including 12 sign languages.
  • Language Parties enable multiplayer audio group conversations.
  • In-app tools offer real-time translations and corrections.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Unlimited Paid Time Off

Parental Leave

401(k) Retirement Plan

Commuter Benefits

Growth & Insights and Company News

Headcount

6 month growth

10%

1 year growth

2%

2 year growth

1%
TechTarget
Apr 3rd, 2026
OpenEvidence enters prescription, prior auth arena.

OpenEvidence enters prescription, prior auth arena. Through a new partnership with Tandem, the clinical decision support platform will include automation capabilities to ease the prescription and prior authorization processes. Published: 03 Apr 2026 OpenEvidence has partnered with Tandem to add prescription generation and prior authorization submission capabilities to its clinical decision support tool. OpenEvidence provides a large language model-based search engine for clinicians. Clinicians can ask the platform medical questions and receive answers based on evidence gathered and synthesized from various sources, including the New England Journal of Medicine, JAMA Network and Mayo Clinic Platform. According to the company, its platform supports more than 1 million clinical consultations per day in the United States. Tandem is an AI-powered tool that automates the prescription process, including prior authorization, appeals and routing prescriptions to the patient's preferred pharmacy. The tool, which is embedded within EHR workflows, also enrolls patients in savings and support programs as needed. The partnership's goals are to reduce delays between diagnosis and treatment, expand patient access to medications and reduce administrative burdens for clinicians. "Clinicians shouldn't have to choose between delivering care and navigating administrative complexity," said Ania Bilski, M.D., vice president of clinical AI at OpenEvidence, in the press release. "By partnering with Tandem, we're removing friction from both clinical and operational workflows - so clinicians can focus on getting patients the right treatments, faster." The partnership follows OpenEvidence's initial push into the revenue cycle management space with the launch of its Coding Intelligence feature late last month. The AI-driven feature automatically provides ICD-10 diagnoses and evaluation and management (E/M) level recommendations within clinical notes. The company has also made other recent moves to diversify its platform. In February, it launched an audio telehealth feature that allows clinicians to call patients using a customizable caller ID name and number. The feature also enables them to securely send and receive text messages and faxes within the OpenEvidence app. These launches come on the heels of a closed series D fundraising round in January that added $250 million to OpenEvidence's coffers. The round, led by Thrive Capital and DST Global, brought the company's total funding to nearly $700 million and sent its valuation soaring to $12 billion. Anuja Vaidya has covered the healthcare industry since 2012. She currently covers the virtual healthcare landscape, including telehealth, remote patient monitoring and digital therapeutics.

AlleyWatch
Feb 2nd, 2026
#NYCtech Week in Review: 1/25/26 - 1/31/26

#NYCtech week in review: 1/25/26 - 1/31/26. With so much going on in the city's thriving ecosystem, it is easy to miss some of the happenings in the space. We keep you abreast of the things that you may have missed in NYC Tech News for the week ending 1/31 including the NYC startup fundings, NYC startup exits, and NYC startup events featuring news for Tandem, Rogo, Talos, and much, much more. Tandem - $100M Series B. Tandem, an AI-powered healthcare platform that automates prescription access tasks for providers and patients, has raised $100M in Series B funding led by Accel. Tandem was founded by Sahir Jaggi in 2023. Rogo - $75M Series C. Rogo, a secure generative AI platform built for financial institutions, has raised $75M in Series C funding led by Sequoia Capital. Founded by Gabriel Stengel, John Willett, and Tumas Rackaitis in 2021, Rogo has now raised a total of $165M+ in reported equity funding. Talos - $45M Series B. Talos, a provider of institutional-grade digital asset trading technology, has raised $45M in Series B funding from investors that include Fidelity, Sony Innovation Fund, a16z crypto, BNY, Karatage, IMC Trading, Robinhood, and QCP. Founded by Anton Katz and Ethan Feldman in 2018, Talos has now raised a total of $190M in reported equity funding. FLORA - $42M Series A. FLORA, a creative AI tool with an infinite canvas for generating and refining text, image, and video outputs, has raised $42M in Series A funding led by Redpoint. Founded by Alexi Li and Weber Wong in 2024, FLORA has now raised a total of $52M in reported equity funding. Outtake - $40M Series B. Outtake, an agentic AI platform for modern attacks, threat classification, and automated response, has raised $40M in Series B funding led by ICONIQ Capital. Founded by Alex Dhillon in 2023, Outtake has now raised a total of $56.5M in reported equity funding. Slice Global - $25M Series A. Slice Global, a global equity compliance and management platform that helps multinational companies automate equity issuance, tracking, and regulatory compliance across countries, has raised $25M in Series A funding led by Insight Partners. Founded by Maor Levran, Samuel Amar, and Yoel Amir in 2023, Slice Global has now raised a total of $32M in reported equity funding. Visitt.io - $22M Series B. Visitt.io, an AI-powered property operations platform for commercial real estate, has raised $22M in Series B funding led by Susquehanna Growth Equity. Visitt.io was founded by Idan Wender, Itay Oren, Ron Heiblum, and Jonathan Kroll in 2015. BoldVoice - $21M Series A. BoldVoice, an accent training app for non-native English speakers, has raised $21M in Series A funding led by Matrix. Founded by Anada Lakra and Ilya Usorov in 2021, BoldVoice has now raised a total of $27.1M in reported equity funding. Lightyear - $16M. Lightyear, a digital telecom lifecycle management platform for enterprise network procurement, inventory, and expense workflows, has raised $16M in funding according to a recent SEC filing. The filing indicates that the round comes from seven investors. Founded by Dennis Thankachan and Ryan Schrack in 2019, Lightyear has now raised a total of $64.6M in reported equity funding. Concourse - $12M Series A. Concourse, a platform providing AI agents that automate financial analysis and workflows for finance teams, has raised $12M in Series A funding led by Standard Capital. Founded by Matthieu Hafemeister and Ted Michaels in 2023, Concourse has now raised a total of $17.2M in reported equity funding. You are seconds away from signing up for the hottest list in NYC Tech! Chakra Labs - $10.1M. Chakra Labs, an AI infrastructure company that turns public web data into structured datasets to power and improve AI model training and inference, has raised $10.1M in funding according to a recent SEC filing. The filing indicates that the round comes from fifty investors. Chakra Labs was founded by Alexander Fung and Nirmal Krishnan in 2024. Pace - $10M. Pace, an AI-powered platform for handling insurance back-office tasks like submission intake, policy servicing, claims and data management, has raised $10M in Venture funding led by Sequoia Capital. Pace was founded by Yonah Mann and Tristan Gosakti in 2024. Chamelio - $10M Seed. Chamelio, a legal intelligence platform for structured analysis, review, and tracking of contracts and critical legal documents for in-house legal teams, has raised $10M in Seed funding led by Work-Bench and Emerge Ventures. Founded by Alex Zilberman, Gal Lellouche, and Gil Banyas in 2024, Chamelio has now raised a total of $13.5M in reported equity funding. Tenbin Labs - $7M Seed. Tenbin Labs, an asset tokenization protocol for onchain capital markets, has raised $7M in Seed funding led by Galaxy Ventures. Tenbin Labs was founded by Yuki Yuminaga and Jake Lang in 2025. Barnwell Bio - $6M Seed. Barnwell Bio, an animal health biosurveillance platform for the analysis of environmental and waste samples, has raised $6M in Seed funding led by Twelve Below. Founded by Michael Rhys in 2024, Barnwell Bio has now raised a total of $12.1M in reported equity funding. Cvector - $5M Seed. Cvector, a real-time industrial data platform that provides high-fidelity operational and economic insights for industrial operators, has raised $5M in Seed funding led by Powerhouse Ventures. Founded by Tyler Ruggles and Richard Zhang in 2024, Cvector has now raised a total of $6.5M in reported equity funding. Datalinx AI - $4.2M Seed. Datalinx AI, a platform that transforms raw enterprise data into clean, structured inputs for AI models and applications by automating data preparation tasks, has raised $4.2M in Seed funding led by High Alpha. Datalinx AI was founded by Alek Liskov, Jeff Collins, Joe Luchs, and Nicole Ferragonio in 2025. Galaxy - $4M. Galaxy, a knowledge graph platform that maps company data into shared meaning, has raised $4M in funding according to a recent SEC filing. The filing indicates that the round comes from five investors. Galaxy was founded by Mitchell Bregman and Leon Kozlowski in 2025. Rookly - $2.5M. Rookly, a scholastic online chess competition platform for school teams, has raised $2.5M in funding according to a recent SEC filing. The filing indicates that there were twenty-three investors in the round. Rookly was founded by Amir Moazami and Matthew Zeitlin in 2021. Checkbox - $2.4M. Checkbox, an AI-powered no-code intake and workflow automation platform that helps in-house legal teams capture, triage, and manage legal work with visibility and efficiency, has raised $2.4M in funding according to a recent SEC filing. The filing indicates that the round comes from six investors. Founded by Evan Wong, James Han, and Paul Wenck in 2016, Checkbox has now raised a total of $8.6M in reported equity funding. Bevel - $500K. Bevel, an AI-powered home inventory tool that turns your photos and videos into a detailed list of your belongings to simplify insurance documentation and disaster recovery, has raised $500K in funding according to a recent SEC filing. The filing indicates that the round comes from a sole investor. Bevel was founded by Adam Freed and Aravindh Dorai in 2024. About alleywatch. Contact.

PYMNTS
Jan 26th, 2026
Tandem Technology to Raise $100 Million for Prescription Automation | PYMNTS.com

HealthTech startup Tandem Technology achieved a valuation of $1 billion, Bloomberg News reported Monday (Jan. 26). The company, which aims to use

Bloomberg L.P.
Jan 26th, 2026
AI-for-Prescriptions Startup Tandem Lands $1 Billion Valuation

Health care technology startup Tandem Technology Inc., which aims to smooth the process of writing and receiving medical prescriptions using artificial intelligence, has reached a valuation of $1 billion, according to people familiar with the matter.